SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,524,057,000 | -10.9% | 27,293 | -28.2% | 0.02% | -23.8% |
| Q1 2021 | $2,833,183,000 | -46.3% | 38,014 | +22.9% | 0.02% | -54.3% |
| Q4 2020 | $5,273,085,000 | +200.2% | 30,929 | +147.3% | 0.05% | +142.1% |
| Q3 2020 | $1,756,358,000 | -18.3% | 12,507 | -6.7% | 0.02% | -24.0% |
| Q2 2020 | $2,149,518,000 | +106.4% | 13,406 | +25.9% | 0.02% | +66.7% |
| Q1 2020 | $1,041,587,000 | -24.9% | 10,648 | -0.9% | 0.02% | +7.1% |
| Q4 2019 | $1,386,148,000 | – | 10,742 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |